Verition Fund Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-68,265
| Closed | -$313K | – | 3112 |
|
|
2025
Q1 | $313K | Buy |
68,265
+26,320
| +63% | +$121K | ﹤0.01% | 2211 |
|
|
2024
Q4 | $201K | Buy |
41,945
+1,660
| +4% | +$7.95K | ﹤0.01% | 2317 |
|
|
2024
Q3 | $189K | Buy |
40,285
+2,927
| +8% | +$13.7K | ﹤0.01% | 2207 |
|
|
2024
Q2 | $211K | Buy |
+37,358
| New | +$211K | ﹤0.01% | 1921 |
|
|
2024
Q1 | – | Sell |
-86,500
| Closed | -$365K | – | 2351 |
|
|
2023
Q4 | $365K | Sell |
86,500
-147,400
| -63% | -$622K | ﹤0.01% | 1283 |
|
|
2023
Q3 | $1.01M | Buy |
+233,900
| New | +$1.01M | 0.01% | 916 |
|
|
2021
Q2 | – | Sell |
-11,493
| Closed | -$173K | – | 2020 |
|
|
2021
Q1 | $173K | Buy |
+11,493
| New | +$173K | ﹤0.01% | 1261 |
|